“…The most commonly reported de novo conditions following CS remission were thyroid disorders ( n = 41, 48.8%), including 34 cases of thyroiditis [ 9 , 10 , 11 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ] and seven cases of Graves disease [ 8 , 9 , 21 , 24 , 25 , 26 ]. Rheumatological disorders were the second most commonly reported conditions ( n = 22, 26.2%) with cases of sarcoidosis ( n = 13) [ 8 , 14 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ], systemic lupus erythematosus ( n = 2) [ 9 , 36 ], rheumatoid arthritis ( n = 2) [ 37 , 38 ], seronegative arthritis ( n = 2) [ 37 , 39 ], polymyalgia rheumatica ( n = 1) [ 40 ], giant cell arteritis ( n = 1) [ 9 ] and retinal vasculitis ( n = 1) [ 39 ] (see Figure 3 and Table 3 ).…”